Tornier BV, a Dutch medical device company focused on surgeons that treat musculoskeletal injuries and disorders, has filed for a $205 million IPO. It plans to trade on the Nasdaq under ticker symbol TRNX, with BoA Merrill Lynch and J.P. Morgan serving as co-lead underwriters.
The company reports around $201 million in 2009 revenue, which is up from $177 million in 2008. Consolidated net loss grew to $55 million from $34 million.
Shareholders include Warburg Pincus, The Vertical Group and company management.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.